119 related articles for article (PubMed ID: 35249515)
1. Modulation of Bleomycin-induced Oxidative Stress and Pulmonary Fibrosis by Ginkgetin in Mice
Ren G; Xu G; Li R; Xie H; Cui Z; Wang L; Zhang C
Curr Mol Pharmacol; 2023; 16(2):217-227. PubMed ID: 35249515
[TBL] [Abstract][Full Text] [Related]
2. Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ.
Mansour HH; Omran MM; Hasan HF; El Kiki SM
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1943-1952. PubMed ID: 32658336
[TBL] [Abstract][Full Text] [Related]
3. Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1.
Wu Y; Shi W; Li H; Liu C; Shimizu K; Li R; Zhang C
Phytomedicine; 2024 Jun; 128():155318. PubMed ID: 38493719
[TBL] [Abstract][Full Text] [Related]
4. Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress.
Ding Y; Wang L; Liu B; Ren G; Okubo R; Yu J; Zhang C
Phytother Res; 2022 Oct; 36(10):3911-3923. PubMed ID: 35794782
[TBL] [Abstract][Full Text] [Related]
5. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ
Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918
[TBL] [Abstract][Full Text] [Related]
6. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms.
Gamad N; Malik S; Suchal K; Vasisht S; Tomar A; Arava S; Arya DS; Bhatia J
Biomed Pharmacother; 2018 Jan; 97():1544-1553. PubMed ID: 29793317
[TBL] [Abstract][Full Text] [Related]
7. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
8. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of ginkgetin on smoke-induced airway inflammation by down-regulating the c/EBPβ signaling pathway and CCL2 expression.
Tao Z; Bai S; Wu G; Zhai S; Zhang P; Fu C; Yu L
J Ethnopharmacol; 2024 Sep; 331():118284. PubMed ID: 38735420
[TBL] [Abstract][Full Text] [Related]
10. Kefir peptides mitigate bleomycin-induced pulmonary fibrosis in mice through modulating oxidative stress, inflammation and gut microbiota.
Lan YW; Chen YC; Yen CC; Chen HL; Tung MC; Fan HC; Chen CM
Biomed Pharmacother; 2024 May; 174():116431. PubMed ID: 38522238
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.
Liu Y; Lu F; Kang L; Wang Z; Wang Y
BMC Pulm Med; 2017 Apr; 17(1):63. PubMed ID: 28420366
[TBL] [Abstract][Full Text] [Related]
12. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
13. Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis.
Wei L; Jian P; Erjiong H; Qihan Z
Chem Biol Drug Des; 2021 Oct; 98(4):620-630. PubMed ID: 34148304
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation.
Shi W; Hao J; Wu Y; Liu C; Shimizu K; Li R; Zhang C
Eur J Pharmacol; 2022 Apr; 921():174825. PubMed ID: 35283110
[TBL] [Abstract][Full Text] [Related]
15. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
16. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
17. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.
Gu X; Han YY; Yang CY; Ji HM; Lan YJ; Bi YQ; Zheng C; Qu J; Cheng MH; Gao J
Pharmacol Res; 2021 Nov; 173():105844. PubMed ID: 34450310
[TBL] [Abstract][Full Text] [Related]
18. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
19. Baicalin alleviates bleomycin‑induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K/AKT signaling pathway.
Zhao H; Li C; Li L; Liu J; Gao Y; Mu K; Chen D; Lu A; Ren Y; Li Z
Mol Med Rep; 2020 Jun; 21(6):2321-2334. PubMed ID: 32323806
[TBL] [Abstract][Full Text] [Related]
20. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
